23rd EuroQSAR

23rd European Symposium on Quantitative Structure-Activity Relationship

Integrative Data-Intensive Approaches to Drug Design

 Heidelberg, Germany    September 26-30, 2022

Premium Exhibitors

Chemotargets SL

Chemotargets is a drug discovery and development organisation offering validated and cutting-edge computational methodologies with market-leading predictive performance.


Optibrium develops elegant software for small molecule design, optimisation and data analysis.

Standard Exhibitors


Founded in 2006, Acellera is a leading company in the use of AI for Drug Discovery. We pioneered GPU acceleration for molecular dynamics simulations and deep learning for structural biology. Our proprietary technology provides the capabilities to simulate proteins and small molecules with atomic precision to obtain new hypotheses, data and knowledge. 

Collaborative Drug Discovery

Collaborative Drug Discovery (CDD) provides an intuitive software suite extensively used by creative biologists and chemists working in academic, biotechnology and pharmaceutical settings.  


Research chemists use Cresset software and contract research solutions to discover, design and optimize the best molecules. Our patented software, and expert molecular modelers, offer unrivalled insight into protein-ligand systems. 


Headquartered in Kyiv, Ukraine, Enamine combines a CRO profile with production and multi-level supply of innovative screening libraries, novel building blocks, fragments, and comprehensive chemistry support in drug discovery services, such as organic synthesis, medicinal chemistry, biological screening, ADME-PK testing, and integrated discovery.


Iktos is a leading ‘AI for de novo drug design’ company with offices in France, UK, and USA. The use of Iktos technology platform enables major productivity gains in upstream pharmaceutical R&D.

OpenEye, Cadence Molecular Sciences

OpenEye, Cadence Molecular Sciences is an industry leader in computational molecular design through rapid, robust, and scalable software, consulting services, and Orion®, the only cloud-native fully integrated software-as-a-service molecular modeling platform that offers unprecedented capabilities for the advancement of pharmaceuticals, biologics, agrochemicals, and flavors and fragrances.

Pharmacelera S ;L.

Through proprietary cutting-edge computational technologies based on a QM description of molecules, Pharmacelera allows researchers not only to find novel hits for challenging targets, but also to optimize chemical series by leveraging the power of 3D AI. 

Schrödinger GmbH

Schrödinger is transforming the way therapeutics and materials are discovered. Schrödinger has pioneered a physics-based software platform that enables discovery of high-quality, novel molecules for drug development and materials applications more rapidly and at lower cost compared to traditional methods.

SpiroChem AG

SpiroChem is a Contract Research Organization (CRO) operating in Basel, Switzerland. SpiroChem is covering the entire discovery chemistry value chain, from proprietary screening libraries (diverse high-sp3 FBL, scaffolds for DELt), then design (FBDD, SBDD, CADD) and synthesis of bioactive molecules (Medicinal Chemistry, Medicinal Chemistry-Enabling platforms), all the way to early CMC (Route-Scouting).

WuXi AppTec

“Every drug can be made and every disease can be treated.” WuXi AppTec provides a broad portfolio of R&D and manufacturing services that enable global pharmaceutical and healthcare industry to advance discoveries and deliver groundbreaking treatments to patients.